Gross Margin
21.35%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 23.86%.Updated Aug 20, 2026Profit Margin
6.78%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Margin
5.67%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Assets (TTM)
1.51%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Equity (TTM)
4.08%vs Specialty Chemicals peers Updated Aug 20, 2026Revenue (TTM)
1.66BCNY246.45M · vs all stocks (USD) Updated Aug 20, 2026Revenue per Share (TTM)
1.64CNYUpdated Aug 20, 2026Quarterly Revenue Growth
13.40%vs Specialty Chemicals peers Updated Aug 20, 2026Gross Profit (TTM)
395.95MCNY58.81M · vs all stocks (USD) Updated Aug 20, 2026EBITDA (TTM)
206.52MCNY30.67M · vs all stocks (USD) Updated Aug 20, 2026Net Income (TTM)
112.54MCNY16.71M · vs all stocks (USD) Updated Aug 20, 2026Quarterly Earnings Growth (YoY)
-84.60%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Cash Flow (TTM)
309.27MCNY45.93M · vs all stocks (USD) Updated Aug 20, 2026Levered Free Cash Flow (TTM)
685.08KCNY101.75K · vs all stocks (USD) Updated Aug 20, 2026Trailing Annual Dividend Rate
0.0125CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.10%Updated Aug 20, 20265-Year Average Dividend Yield
0.42%Updated Aug 20, 2026Payout Ratio
50.00%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 11.36%.Updated Aug 20, 2026Minority Interest (Equity)
1.16BCNYFY2025 · Dec 31, 2025Revenue
1.61BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.21BCNYFY2025 · Dec 31, 2025Gross Profit
401.56MCNYFY2025 · Dec 31, 2025Operating Income
153.34MCNY22.77M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
204.43MCNYFY2025 · Dec 31, 2025Income Tax Expense
8.22MCNYFY2025 · Dec 31, 2025Net Income
196.21MCNYFY2025 · Dec 31, 2025EBIT
255.48MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
485.13MCNYFY2025 · Dec 31, 2025Research & Development
102.44MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
63.83MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.17MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.81MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
51.05MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1333CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1333CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.12BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.12BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
196.21MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-46.85MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
188.64MCNYFY2025 · Dec 31, 2025Free Cash Flow
23.23MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
546.44MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
196.21MCNYFY2025 · Dec 31, 2025Other Non-cash Items
51.67MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-25.03MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-34.19MCNYFY2025 · Dec 31, 2025Capital Expenditures
-165.41MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.46BCNYFY2025 · Dec 31, 2025Sale of Investments
4.19BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-432.00MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
160.47MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-183.70MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-72.81MCNYFY2025 · Dec 31, 2025Other Financing Charges
-8.93MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-104.97MCNYFY2025 · Dec 31, 2025